ZHONGZHIPHARM (03737) Income Statement & Earnings

0.870
+0.040+4.82%

Trading May 6 15:35 CST

751.33MMarket Cap39.55P/E (TTM)

ZHONGZHIPHARM (03737) Income Statement

All

YOY

Hide blank lines

(FY)Dec 31, 2025

(Q6)Jun 30, 2025

(FY)Dec 31, 2024

(Q6)Jun 30, 2024

(FY)Dec 31, 2023

(Q6)Jun 30, 2023

(FY)Dec 31, 2022

(Q6)Jun 30, 2022

(FY)Dec 31, 2021

(Q6)Jun 30, 2021

Turnover

-21.55%1.74B

-19.11%880.48M

8.05%2.21B

-0.54%1.09B

12.26%2.05B

29.29%1.09B

4.55%1.83B

-4.55%846.4M

8.89%1.75B

20.20%886.72M

Operating income

-21.55%1.74B

-19.11%880.48M

8.05%2.21B

-0.54%1.09B

12.26%2.05B

29.29%1.09B

4.55%1.83B

-4.55%846.4M

8.89%1.75B

20.20%886.72M

Cost of sales

14.55%-791.6M

13.75%-397.96M

-11.39%-926.38M

-10.02%-461.38M

-10.35%-831.67M

-22.90%-419.37M

-10.01%-753.64M

-0.09%-341.21M

-11.82%-685.06M

-21.96%-340.9M

Operating expenses

14.55%-791.6M

13.75%-397.96M

-11.39%-926.38M

-10.02%-461.38M

-10.35%-831.67M

-22.90%-419.37M

-10.01%-753.64M

-0.09%-341.21M

-11.82%-685.06M

-21.96%-340.9M

Gross profit

-26.58%945.89M

-23.05%482.52M

5.77%1.29B

-7.10%627.05M

13.60%1.22B

33.61%674.96M

1.02%1.07B

-7.44%505.18M

7.09%1.06B

19.13%545.82M

Selling expenses

19.73%-793.62M

9.53%-405.74M

-11.32%-988.74M

-0.79%-448.48M

-9.67%-888.16M

-27.13%-444.96M

2.34%-809.82M

12.23%-350M

-18.67%-829.24M

-34.02%-398.75M

Administrative expenses

5.20%-100.25M

6.02%-49.48M

0.85%-105.75M

2.00%-52.65M

-1.82%-106.65M

-9.19%-53.72M

-1.79%-104.75M

-4.50%-49.2M

-12.12%-102.9M

-7.31%-47.08M

Impairment and provision

81.46%-760K

32.39%-2.77M

-764.98%-4.1M

---4.1M

---474K

----

-Other impairment is provision

81.46%-760K

32.39%-2.77M

-764.98%-4.1M

---4.1M

---474K

----

Special items of operating profit

25.15%-26.9M

-68.83%-20.98M

-384.74%-35.93M

-162.89%-12.42M

63.88%-7.41M

38.13%-4.73M

66.03%-20.52M

53.35%-7.64M

-114.32%-60.41M

26.46%-16.37M

Operating profit

-84.17%24.37M

-96.75%3.56M

-28.57%153.89M

-36.23%109.4M

57.03%215.45M

74.44%171.56M

99.16%137.21M

17.62%98.35M

-60.05%68.89M

-11.52%83.62M

Financing cost

23.09%-5.38M

32.47%-2.96M

11.11%-6.99M

-17.10%-4.38M

-20.03%-7.87M

-27.49%-3.74M

7.42%-6.56M

15.19%-2.94M

-35.68%-7.08M

-33.93%-3.46M

Earning before tax

-87.07%18.99M

-99.43%600K

-29.23%146.9M

-37.42%105.02M

58.88%207.58M

75.89%167.82M

111.36%130.65M

19.04%95.41M

-63.04%61.81M

-12.79%80.16M

Tax

97.47%-1.29M

139.57%8.22M

-16.81%-50.75M

34.42%-20.77M

-83.04%-43.45M

-77.16%-31.67M

-151.25%-23.74M

-31.32%-17.88M

66.97%-9.45M

31.64%-13.61M

After-tax profit from continuing operations

-81.59%17.7M

-89.53%8.82M

-41.42%96.15M

-38.12%84.25M

53.52%164.13M

75.59%136.15M

104.17%106.92M

16.52%77.54M

-62.22%52.37M

-7.58%66.54M

Earning after tax

-81.59%17.7M

-89.53%8.82M

-41.42%96.15M

-38.12%84.25M

53.52%164.13M

75.59%136.15M

104.17%106.92M

16.52%77.54M

-62.22%52.37M

-7.58%66.54M

Minority profit

-55.94%412K

-95.81%34K

-31.20%935K

-35.14%812K

157.39%1.36M

154.99%1.25M

121.85%528K

1,215.91%491K

173.56%238K

-4,300.00%-44K

Profit attributable to shareholders

-81.84%17.29M

-89.47%8.78M

-41.51%95.21M

-38.15%83.44M

53.00%162.78M

75.09%134.9M

104.09%106.39M

15.71%77.05M

-62.37%52.13M

-7.52%66.59M

Basic earnings per share

-81.82%0.02

-89.90%0.01

-42.11%0.11

-37.74%0.099

46.15%0.19

74.73%0.159

116.67%0.13

12.35%0.091

-64.71%0.06

-5.81%0.081

Diluted earnings per share

-81.82%0.02

-89.90%0.01

-42.11%0.11

-37.74%0.099

46.15%0.19

74.73%0.159

116.67%0.13

12.35%0.091

-64.71%0.06

-5.81%0.081

Currency Unit

CNY

Accounting Standards

IAS

Audit Opinions

Unqualified Opinion

Auditor

Ernst & Young

	(FY)Dec 31, 2025	(Q6)Jun 30, 2025	(FY)Dec 31, 2024	(Q6)Jun 30, 2024	(FY)Dec 31, 2023	(Q6)Jun 30, 2023	(FY)Dec 31, 2022	(Q6)Jun 30, 2022	(FY)Dec 31, 2021	(Q6)Jun 30, 2021
Turnover	-21.55%1.74B	-19.11%880.48M	8.05%2.21B	-0.54%1.09B	12.26%2.05B	29.29%1.09B	4.55%1.83B	-4.55%846.4M	8.89%1.75B	20.20%886.72M
Operating income	-21.55%1.74B	-19.11%880.48M	8.05%2.21B	-0.54%1.09B	12.26%2.05B	29.29%1.09B	4.55%1.83B	-4.55%846.4M	8.89%1.75B	20.20%886.72M
Cost of sales	14.55%-791.6M	13.75%-397.96M	-11.39%-926.38M	-10.02%-461.38M	-10.35%-831.67M	-22.90%-419.37M	-10.01%-753.64M	-0.09%-341.21M	-11.82%-685.06M	-21.96%-340.9M
Operating expenses	14.55%-791.6M	13.75%-397.96M	-11.39%-926.38M	-10.02%-461.38M	-10.35%-831.67M	-22.90%-419.37M	-10.01%-753.64M	-0.09%-341.21M	-11.82%-685.06M	-21.96%-340.9M
Gross profit	-26.58%945.89M	-23.05%482.52M	5.77%1.29B	-7.10%627.05M	13.60%1.22B	33.61%674.96M	1.02%1.07B	-7.44%505.18M	7.09%1.06B	19.13%545.82M
Selling expenses	19.73%-793.62M	9.53%-405.74M	-11.32%-988.74M	-0.79%-448.48M	-9.67%-888.16M	-27.13%-444.96M	2.34%-809.82M	12.23%-350M	-18.67%-829.24M	-34.02%-398.75M
Administrative expenses	5.20%-100.25M	6.02%-49.48M	0.85%-105.75M	2.00%-52.65M	-1.82%-106.65M	-9.19%-53.72M	-1.79%-104.75M	-4.50%-49.2M	-12.12%-102.9M	-7.31%-47.08M
Impairment and provision	81.46%-760K	32.39%-2.77M	-764.98%-4.1M	---4.1M	---474K	----	----	----	----	----
-Other impairment is provision	81.46%-760K	32.39%-2.77M	-764.98%-4.1M	---4.1M	---474K	----	----	----	----	----
Special items of operating profit	25.15%-26.9M	-68.83%-20.98M	-384.74%-35.93M	-162.89%-12.42M	63.88%-7.41M	38.13%-4.73M	66.03%-20.52M	53.35%-7.64M	-114.32%-60.41M	26.46%-16.37M
Operating profit	-84.17%24.37M	-96.75%3.56M	-28.57%153.89M	-36.23%109.4M	57.03%215.45M	74.44%171.56M	99.16%137.21M	17.62%98.35M	-60.05%68.89M	-11.52%83.62M
Financing cost	23.09%-5.38M	32.47%-2.96M	11.11%-6.99M	-17.10%-4.38M	-20.03%-7.87M	-27.49%-3.74M	7.42%-6.56M	15.19%-2.94M	-35.68%-7.08M	-33.93%-3.46M
Earning before tax	-87.07%18.99M	-99.43%600K	-29.23%146.9M	-37.42%105.02M	58.88%207.58M	75.89%167.82M	111.36%130.65M	19.04%95.41M	-63.04%61.81M	-12.79%80.16M
Tax	97.47%-1.29M	139.57%8.22M	-16.81%-50.75M	34.42%-20.77M	-83.04%-43.45M	-77.16%-31.67M	-151.25%-23.74M	-31.32%-17.88M	66.97%-9.45M	31.64%-13.61M
After-tax profit from continuing operations	-81.59%17.7M	-89.53%8.82M	-41.42%96.15M	-38.12%84.25M	53.52%164.13M	75.59%136.15M	104.17%106.92M	16.52%77.54M	-62.22%52.37M	-7.58%66.54M
Earning after tax	-81.59%17.7M	-89.53%8.82M	-41.42%96.15M	-38.12%84.25M	53.52%164.13M	75.59%136.15M	104.17%106.92M	16.52%77.54M	-62.22%52.37M	-7.58%66.54M
Minority profit	-55.94%412K	-95.81%34K	-31.20%935K	-35.14%812K	157.39%1.36M	154.99%1.25M	121.85%528K	1,215.91%491K	173.56%238K	-4,300.00%-44K
Profit attributable to shareholders	-81.84%17.29M	-89.47%8.78M	-41.51%95.21M	-38.15%83.44M	53.00%162.78M	75.09%134.9M	104.09%106.39M	15.71%77.05M	-62.37%52.13M	-7.52%66.59M
Basic earnings per share	-81.82%0.02	-89.90%0.01	-42.11%0.11	-37.74%0.099	46.15%0.19	74.73%0.159	116.67%0.13	12.35%0.091	-64.71%0.06	-5.81%0.081
Diluted earnings per share	-81.82%0.02	-89.90%0.01	-42.11%0.11	-37.74%0.099	46.15%0.19	74.73%0.159	116.67%0.13	12.35%0.091	-64.71%0.06	-5.81%0.081
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS
Audit Opinions	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--
Auditor	Ernst & Young	--	Ernst & Young	--	Ernst & Young	--	Ernst & Young	--	Ernst & Young	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More

牛牛課堂

Oct 13, 2025 18:05

[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?

Food流油

Apr 14, 2025 15:43

"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"